BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23518352)

  • 1. SnapShot: pancreatic cancer.
    Han H; Von Hoff DD
    Cancer Cell; 2013 Mar; 23(3):424-424.e1. PubMed ID: 23518352
    [No Abstract]   [Full Text] [Related]  

  • 2. The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies.
    Adsay NV
    Surgery; 2003 May; 133(5):459-63. PubMed ID: 12773972
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic strategy for intractable pancreatic cancer and its fundamental research.
    Cho K; Ishiwata T; Naito Z; Uchida E
    J Nippon Med Sch; 2010 Feb; 77(1):62-3. PubMed ID: 20154464
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical characteristics of invasive ductal carcinomas of the pancreas according to the histological differentiation].
    Yamaue H
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():48-51. PubMed ID: 16457220
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of and predictive risk factors for intraductal papillary mucinous neoplasm of the pancreas with ordinary pancreatic cancer.
    Okabayashi T; Nishimori I; Maeda H; Hanazaki K
    J Clin Gastroenterol; 2010 Jan; 44(1):75-6. PubMed ID: 19564793
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible electroporation: a novel therapy for stage III pancreatic cancer.
    Weiss MJ; Wolfgang CL
    Adv Surg; 2014; 48():253-8. PubMed ID: 25293620
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating pancreatic cancer: more antioxidants more problems?
    Alexander MS; Cullen JJ
    Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):849-851. PubMed ID: 29956580
    [No Abstract]   [Full Text] [Related]  

  • 9. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.
    Fogel EL; Shahda S; Sandrasegaran K; DeWitt J; Easler JJ; Agarwal DM; Eagleson M; Zyromski NJ; House MG; Ellsworth S; El Hajj I; O'Neil BH; Nakeeb A; Sherman S
    Am J Gastroenterol; 2017 Apr; 112(4):537-554. PubMed ID: 28139655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma of the exocrine pancreas: the histology report.
    Capella C; Albarello L; Capelli P; Sessa F; Zamboni G; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S282-92. PubMed ID: 21459334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic ductal carcinoma: from the bench to the bedside.
    Pezzilli R
    JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.
    Semaan A; Maitra A
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenging Topics in Pancreatic Neoplasia.
    Basturk O; Krasinskas AM
    Arch Pathol Lab Med; 2020 Jul; 144(7):806-807. PubMed ID: 33761530
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of pancreatic ductal adenocarcinoma].
    Sato R; Kishiwada M; Isaji S
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():95-9. PubMed ID: 25856992
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics of pancreatic ductal adenocarcinoma.
    Pilarsky C; Grutzmann R
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A white paper: the product of a pancreas cancer think tank.
    Kern S; Hruban R; Hollingsworth MA; Brand R; Adrian TE; Jaffee E; Tempero MA
    Cancer Res; 2001 Jun; 61(12):4923-32. PubMed ID: 11406572
    [No Abstract]   [Full Text] [Related]  

  • 19. Precursors of pancreatic cancer.
    Frič P; Škrha J; Šedo A; Bušek P; Laclav M; Bunganič B; Zavoral M
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):e13-e18. PubMed ID: 28009716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and characteristics of pancreatic cystic neoplasms].
    Adet A; Miquel R; Bombi JA; Gines A; Fernández-Esparrach G; De Juan C; Ayuso JR; Maurel J; Castells A; Fernández-Cruz L; Navarro S
    Gastroenterol Hepatol; 2010 Oct; 33(8):563-8. PubMed ID: 20850905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.